Skip to main content
electroCore, Inc. logo

electroCore, Inc. — Investor Relations & Filings

Ticker · ECOR ISIN · US28531P2020 LEI · 5493005O3QC5QV2L2186 US Manufacturing
Filings indexed 453 across all filing types
Latest filing 2026-03-20 Director's Dealing
Country US United States of America
Listing US ECOR

About electroCore, Inc.

https://www.electrocore.com/

electroCore, Inc. is a commercial-stage bioelectronic medicine company focused on developing and commercializing non-invasive vagus nerve stimulation (nVNS) therapy. The company's proprietary technology platform is designed to treat multiple conditions, primarily in neurology. Its key products, including gammaCore™, are handheld devices that provide a non-invasive method for stimulating the vagus nerve to manage and treat various medical conditions and support general wellness. The company aims to provide innovative solutions for patients suffering from pain and chronic ailments.

Recent filings

Filing Released Lang Actions
4 - electroCore, Inc. (0001560258) (Issuer)
Director's Dealing
2026-03-20 English
S-8 - electroCore, Inc. (0001560258) (Filer)
Registration Form
2026-03-19 English
10-K - electroCore, Inc. (0001560258) (Filer)
Annual Report FY 2025
2026-03-19 English
4 Filing
Director's Dealing
2026-01-28 English
4 Filing
Director's Dealing
2026-01-28 English
8-K Filing
Regulatory Filings
2026-01-20 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.